WallStreetZenWallStreetZen

NASDAQ: APRE
Aprea Therapeutics Inc Stock Ownership - Who owns Aprea Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aprea Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Oren GiladPresidentCEO2026-01-3028,100$0.89
$25.01kBuy
John P. HamillSrVPCFOPrin Fin Acct Ofcr2026-01-305,700$0.89
$5.07kBuy
Marc DueyDirector2025-12-1021,459$1.17
$25.00kBuy
John P. HamillSrVPCFOPrin Fin Acct Ofcr2025-12-105,000$1.17
$5.83kBuy

1 of 1

APRE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APRE insiders and whales buy or sell their stock.

APRE Shareholders

What type of owners hold Aprea Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Tryant LLC226.12%28,000,000$20.02MInsider
Thomas Banks108.14%13,391,146$9.57MInsider
Frank J. Hall38.62%4,781,889$3.42MInsider
David West Wilson23.62%2,924,726$2.09MInsider
Heidi A. Patterson21.71%2,688,221$1.92MInsider
Kdev Investments Ab16.09%1,992,586$1.42MInsider
Michael Reynolds15.99%1,980,040$1.42MInsider
Redmile Group LLC14.28%1,768,718$1.26MInsider
Aigh Capital Management LLC8.20%1,015,541$726.11kInstitution
Oren Gilad3.20%395,695$282.92kInsider

1 of 3

APRE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APRE3.63%96.37%Net Buying
CVM7.71%92.29%Net BuyingNet Buying
IMRN0.03%1.91%
JUNS5.25%31.12%Net Buying
ASBP4.99%95.01%
View Top Biotech Stocks

Aprea Therapeutics Stock Ownership FAQ

Who owns Aprea Therapeutics?

Aprea Therapeutics (NASDAQ: APRE) is owned by 18.12% institutional shareholders, 480.58% Aprea Therapeutics insiders, and 0.00% retail investors. Tryant LLC is the largest individual Aprea Therapeutics shareholder, owning 28.00M shares representing 226.12% of the company. Tryant LLC's Aprea Therapeutics shares are currently valued at $20.02M.

If you're new to stock investing, here's how to buy Aprea Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.